Literature DB >> 2970390

Clonal variation in childhood acute lymphoblastic leukaemia at early and late relapse detected by analyses of phenotype and genotype.

A Raghavachar1, W D Ludwig, C R Bartram.   

Abstract

To increase our knowledge of the clonal relationship of leukaemia relapse, the genotypes and phenotypes of ten children with acute lymphoblastic leukaemia (ALL) were examined at initial diagnosis and relapse. Seven patients were phenotyped as common ALL, two as mixed, and one as T-cell ALL (T-ALL). Comparative analyses of immunoglobulin (Ig) heavy and light chain as well as T-cell receptor beta-chain (T beta) sequences revealed clonal variations, i.e. appearance of a novel or an evoluted leukaemic cell clone in five patients coinciding with the loss of common acute lymphoblastic leukaemic antigen (CALLA) in four cases, irrespective of early or late relapse. Conversion of early B- to T-ALL or lymphoblastic to non-lymphoblastic leukaemia was not noted in any of the patients examined. Our results suggest that clonal variation is a frequent event in childhood ALL.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970390     DOI: 10.1007/bf00441975

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

1.  Relapse patterns in Burkitt's lymphoma.

Authors:  J L Ziegler; A Z Bluming; L Fass; R H Morrow
Journal:  Cancer Res       Date:  1972-06       Impact factor: 12.701

2.  Acute lymphoblastic leukaemia associated antigen. III ALterations in expression during treatment and in relapse.

Authors:  M Greaves; A Paxton; G Janossy; C Pain; S Johnson; T A Lister
Journal:  Leuk Res       Date:  1980       Impact factor: 3.156

3.  Shifts in expression of cell membrane phenotypes in childhood lymphoid malignancies at relapse.

Authors:  L Borella; J T Casper; S J Lauer
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

4.  T-cell receptor gene rearrangements as markers of lineage and clonality in T-cell neoplasms.

Authors:  F Flug; P G Pelicci; F Bonetti; D M Knowles; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study.

Authors:  G K Rivera; G Buchanan; J M Boyett; B Camitta; J Ochs; D Kalwinsky; M Amylon; T J Vietti; W M Crist
Journal:  N Engl J Med       Date:  1986-07-31       Impact factor: 91.245

6.  Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms.

Authors:  A Arnold; J Cossman; A Bakhshi; E S Jaffe; T A Waldmann; S J Korsmeyer
Journal:  N Engl J Med       Date:  1983-12-29       Impact factor: 91.245

7.  Evidence for clonal development of childhood acute lymphoblastic leukemia.

Authors:  L W Dow; P Martin; J Moohr; M Greenberg; L G Macdougall; V Najfeld; P J Fialkow
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

8.  Bone marrow and extramedullary variations of cell membrane antigen expression in childhood lymphoid neoplasias at relapse.

Authors:  S Lauer; V Piaskowski; B Camitta; J Casper
Journal:  Leuk Res       Date:  1982       Impact factor: 3.156

9.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

10.  Shifts in blast cell phenotype and karyotype at relapse of childhood lymphoblastic leukemia.

Authors:  C H Pui; S C Raimondi; F G Behm; J Ochs; W L Furman; N J Bunin; R C Ribeiro; P A Tinsley; J Mirro
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

View more
  2 in total

Review 1.  The EEG and neuroimaging in the management of the epilepsies.

Authors:  N V O'Donohoe
Journal:  Arch Dis Child       Date:  1995-12       Impact factor: 3.791

2.  Communication development in Angelman's syndrome.

Authors:  N Jolleff; M M Ryan
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.